{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:29:38Z","timestamp":1792787378659,"version":"4.5.0"},"reference-count":140,"publisher":"Informa UK Limited","issue":"3","funder":[{"DOI":"10.13039\/100017239","name":"BeiGene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017239","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2025,2,23]]},"DOI":"10.1080\/10428194.2024.2431563","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T20:33:56Z","timestamp":1733949236000},"page":"433-450","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Challenges of treating mantle cell lymphoma in older adults"],"prefix":"10.1080","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9060-8911","authenticated-orcid":false,"given":"Javier","family":"Mu\u00f1oz","sequence":"first","affiliation":[{"name":"Mayo Clinic","place":["Phoenix, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1215-4210","authenticated-orcid":false,"given":"Mazie","family":"Tsang","sequence":"additional","affiliation":[{"name":"Mayo Clinic","place":["Phoenix, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1576-8341","authenticated-orcid":false,"given":"Yucai","family":"Wang","sequence":"additional","affiliation":[{"name":"Mayo Clinic","place":["Rochester, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2143-9672","authenticated-orcid":false,"given":"Tycel","family":"Phillips","sequence":"additional","affiliation":[{"name":"City of Hope Duarte Cancer Center","place":["Duarte, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24086"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27202"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/2040620717719616"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23608"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2018.12.002"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015851"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-093401"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-01977-y"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01520-7"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02698"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16317"},{"key":"e_1_3_3_14_1","doi-asserted-by":"crossref","unstructured":"Pahnke SAK Abalo K Ekberg S et\u00a0al. Clinical characteristics and outcomes of MCL patients aged 80 years and older. Poster presented at: the 29th European Hematology Association Congress; 2024 Jun 13; Abstr. P1129.","DOI":"10.1038\/s41408-024-01204-6"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-095331"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000928"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx223"},{"key":"e_1_3_3_18_1","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): B-cell lymphomas. Version 1.2024; 2024 [cited 2024 Jun 20]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/b-cell.pdf"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.4158"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01789-X"},{"issue":"11","key":"e_1_3_3_21_1","first-page":"687524","article-title":"The role of the comprehensive geriatric assessment in the evaluation of the older cancer patient","volume":"33","author":"Blanquicett C","year":"2019","unstructured":"Blanquicett C, Cohen JB, Flowers C, et\u00a0al. The role of the comprehensive geriatric assessment in the evaluation of the older cancer patient. Oncology. 2019;33(11):687524.","journal-title":"Oncology"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2016.11.002"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0247"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.2.494"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1331246"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac145"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00933"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/OP.23.00263"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)30185-5"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-187346"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr587"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17554"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.282252"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2008.04.004"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx333"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1455973"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30068"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.201350"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-017-0652-8"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00605"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-531327"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61763-2"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.7503"},{"key":"e_1_3_3_44_1","unstructured":"Wang M Mayer J Belada D et\u00a0al. Acalabrutinib plus bendamustine and rituximab in untreated mantle cell lymphoma: results from the phase 3 double-blind placebo-controlled ECHO trial. Abstract LB3439 presented at European Hematology Association (EHA); 2024 Jun 13\u201316; Madrid."},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2201817"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.133"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01294"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200920"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412096"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30685-5"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009744"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-07-859769"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505237"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010606"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01797"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-181216"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000971252.93458.20"},{"key":"e_1_3_3_58_1","first-page":"2073","article-title":"Preliminary safety and efficacy of BOVEN (zanubrutinib, obinutuzumab, and venetoclax) for frontline therapy for older patients with mantle cell lymphoma","volume":"8","author":"Kumar ASJ","year":"2024","unstructured":"Kumar ASJ, Karmali R, Abramson JS, et\u00a0al. Preliminary safety and efficacy of BOVEN (zanubrutinib, obinutuzumab, and venetoclax) for frontline therapy for older patients with mantle cell lymphoma. Hemasphere. 2024;8:2073.","journal-title":"Hemasphere"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34412"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002068"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2797"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15722"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17513"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011305"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-022-01286-0"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00902-x"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00687"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1177\/20406207221093980"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-016-0250-9"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70069-9"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025563"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.28_suppl.019"},{"key":"e_1_3_3_73_1","unstructured":"ClinicalTrials.gov. Study comparing zanubrutinib\u00a0+\u00a0rituximab versus bendamustine\u00a0+\u00a0rituximab in participants with untreated mantle cell lymphoma NCT04002297; 2024 [cited 2024 Jun 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04002297"},{"key":"e_1_3_3_74_1","unstructured":"ISRCTN Registry. ISRCTN11038174: ENRICH Ibrutinib for untreated mantle cell lymphoma; 2024 [updated 2024 Jul 23; cited 2024 Oct 11]. Available from: https:\/\/www.isrctn.com\/ISRCTN11038174"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-779736"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-188788"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.34.15_suppl.7503"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-129404"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.7006"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-635326"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306220"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0023-2"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00667-4"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-191921"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00438-6"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30018-8"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0575-9"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33108-2"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014162"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3703"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020004074"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00562"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70200-0"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4842"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.4320"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011920"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.9665"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn656"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25792"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12008"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.49.2835"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07626.x"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.3429"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt366"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023023525"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11080764"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018674"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.198812"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25796"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0537-5"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.0001"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00447-7"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16416"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2010.n.055"},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02254-2"},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701618268"},{"key":"e_1_3_3_117_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914347"},{"key":"e_1_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02214"},{"key":"e_1_3_3_119_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01797"},{"key":"e_1_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.87"},{"key":"e_1_3_3_121_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.7016"},{"key":"e_1_3_3_122_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02470"},{"key":"e_1_3_3_123_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-174956"},{"key":"e_1_3_3_124_1","unstructured":"ClinicalTrials.gov. Testing continuous versus intermittent treatment with the study drug zanubrutinib for older patients with previously untreated mantle cell lymphoma NCT05976763; 2024 [cited 2024 Jun 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05976763"},{"key":"e_1_3_3_125_1","unstructured":"ClinicalTrials.gov. CAR-T-cell treatment for untreated high risk mantle cell lymphoma (CARMAN) NCT06482684; 2024 [cited 2024 Oct 30]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06482684"},{"key":"e_1_3_3_126_1","unstructured":"ClinicalTrials.gov. A study of acalabrutinib plus venetoclax and rituximab in participants with treatment na\u00efve mantle cell lymphoma (TrAVeRse) NCT05951959; 2024 [cited 2024 Jun 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05951959"},{"key":"e_1_3_3_127_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-174718"},{"key":"e_1_3_3_128_1","unstructured":"ClinicalTrials.gov. Zanubrutinib and tafasitamab in mantle cell lymphoma (ZANU-TAFA) NCT06029309; 2024 [cited 2024 Jun 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06029309"},{"key":"e_1_3_3_129_1","unstructured":"ClinicalTrials.gov. Study of BTK inhibitor LOXO-305 versus approved BTK inhibitor drugs in patients with mantle cell lymphoma (MCL) (BRUIN-MCL-321) NCT04662255; 2024 [cited 2024 Jun 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04662255"},{"key":"e_1_3_3_130_1","unstructured":"ClinicalTrials.gov. A study to evaluate glofitamab as a single agent vs. investigator\u2019s choice in participants with relapsed\/refractory mantle cell lymphoma (GLOBRYTE) NCT06084936; 2024 [cited 2024 Jun 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06084936"},{"key":"e_1_3_3_131_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-173946"},{"key":"e_1_3_3_132_1","unstructured":"ClinicalTrials.gov. A phase 2 trial of glofitamab and pirtobrutinib in mantle cell lymphoma patients with prior BTK inhibitor exposure (GOlDiLOX) NCT05833763; 2024 [cited 2024 Jun 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05833763"},{"key":"e_1_3_3_133_1","unstructured":"ClinicalTrials.gov. Phase II palbociclib\u00a0+\u00a0ibrutinib in mantle cell lymphoma NCT03478514; 2024 [cited 2024 Jun 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03478514"},{"key":"e_1_3_3_134_1","unstructured":"ClinicalTrials.gov. A study of zilovertamab vedotin (MK-2140) as monotherapy and in combination in participants with aggressive and indolent B-cell malignancies (MK-2140-006) NCT05458297; 2024 [cited 2024 Jun 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05458297"},{"key":"e_1_3_3_135_1","unstructured":"ClinicalTrials.gov. A study of cirmtuzumab and ibrutinib in patients with B-cell lymphoid malignancies NCT03088878; 2024 [cited 2024 Jun 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03088878"},{"key":"e_1_3_3_136_1","unstructured":"ClinicalTrials.gov. A study of imvotamab monotherapy and in combination in subjects with relapsed\/refractory non-Hodgkin lymphoma NCT04082936; 2024 [cited 2024 Jun 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04082936"},{"key":"e_1_3_3_137_1","unstructured":"ClinicalTrials.gov. Study of BGB-11417 monotherapy in participants with relapsed or refractory mantle cell lymphoma NCT05471843; 2024 [cited 2024 Jun 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05471843"},{"key":"e_1_3_3_138_1","unstructured":"ClinicalTrials.gov. A study of nemtabrutinib (MK-1026) in participants with relapsed or refractory hematologic malignancies (ARQ 531-101\/MK-1026-001) NCT03162536; 2024 [cited 2024 Jun 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03162536"},{"key":"e_1_3_3_139_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153283"},{"key":"e_1_3_3_140_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007247"},{"key":"e_1_3_3_141_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019852368"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2024.2431563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:02:09Z","timestamp":1740355329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2024.2431563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":140,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2,23]]}},"alternative-id":["10.1080\/10428194.2024.2431563"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2024.2431563","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-07-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}